Avaleht › Atoopiline dermatiit (ekseem) › California
Atoopiline dermatiit (ekseem) kliinilised uuringud osariigis California
30 uuringut haiguse Atoopiline dermatiit (ekseem) jaoks otsivad osalejaid osariigis California.
Linnad osariigis California
- Los Angeles11 uuringut
- San Diego10 uuringut
- Huntington Beach8 uuringut
- Sacramento8 uuringut
- Santa Monica6 uuringut
- Santa Clarita6 uuringut
- Fremont4 uuringut
- San Francisco4 uuringut
Ametlik uuringutekst (inglise keeles)
A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)
- First OC Dermatology, Irvine
VärbamineFaas 1Terved vabatahtlikud oodatud
Vanused 18–72 · Kõik sood · Uuendatud 29. sept 2026 · NCT06808477This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
- Kern Research, Inc.- Site Number : 8400047, Bakersfield
- Center for Dermatology Clinical Research- Site Number : 8400014, Fremont
- Dermatology Research Associates - Los Angeles- Site Number : 8400020, Los Angeles
- ja veel 4
VärbamineVaatlusuuring
Vanused 12 ja vanemad · Kõik sood · Uuendatud 29. sept 2026 · NCT07290803Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
- Novartis Investigative Site, Fountain Valley
- Novartis Investigative Site, Los Angeles
- Novartis Investigative Site, Sacramento
- ja veel 2
VärbamineFaas 2
Vanused 18–100 · Kõik sood · Uuendatud 28. sept 2026 · NCT06947993Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Enveda Investigative Site, Beverly Hills
- Enveda Investigative Site, Fremont
- Enveda Investigative Site, San Diego
- ja veel 3
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 25. sept 2026 · NCT07298395First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
- Alliance Clinical West Hills (Focus Clinical Research), West Hills
VärbamineFaas 1Terved vabatahtlikud oodatud
Vanused 18–65 · Kõik sood · Uuendatud 25. sept 2026 · NCT07527923A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
- Investigational Drug Service - Rady Childrens Hospital-San Diego, San Diego
- University of California, San Diego/ Rady Children's Hospital - San Diego, San Diego
VärbamineFaas 3
Vanused 2–11 · Kõik sood · Uuendatud 25. sept 2026 · NCT06807281A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
- Marvel Clinical Research, Huntington Beach
- Metropolis Dermatology - DTLA, Los Angeles
- Northridge Clinical Trials, Northridge
- ja veel 1
VärbamineFaas 2
Vanused 18–64 · Kõik sood · Uuendatud 25. sept 2026 · NCT07216027A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
- Investigational Site, Fountain Valley
- Investigational Site, Los Angeles
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 23. sept 2026 · NCT07003425The Impact of Dietary Salt on the Severity of Eczema
- San Francisco VA Medical Center, San Francisco
- UCSF Mt Zion Campus, San Francisco
VärbamineFaas 4Terved vabatahtlikud oodatud
Vanused 18 ja vanemad · Kõik sood · Uuendatud 10. sept 2026 · NCT07447063The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease
- UCSF Mt Zion Campus, San Francisco
- San Francisco VA Medical Center, San Francisco
VärbamineFaas 4Terved vabatahtlikud oodatud
Vanused 18 ja vanemad · Kõik sood · Uuendatud 9. sept 2026 · NCT07487831A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis
- UCLA Division of Dermatology, Los Angeles
- Dermatology Research Associate, Los Angeles
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 4. sept 2026 · NCT07223697A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
- Northridge Clinical Trials, Northridge
VärbamineFaas 3
Vanused 12 ja vanemad · Kõik sood · Uuendatud 4. sept 2026 · NCT07765888A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- Marvel Research, LLC, Huntington Beach
- Metropolis Dermatology, Los Angeles
- Dermatology Research Associates, Los Angeles
- ja veel 4
VärbamineFaas 2
Vanused 18–65 · Kõik sood · Uuendatud 28. aug 2026 · NCT07599813Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.
- Allergy and Asthma Medical Group and Research Center, San Diego
VärbamineVaatlusuuring
Vanused 12 ja vanemad · Kõik sood · Uuendatud 17. aug 2026 · NCT06899204Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over Time in Atopic Dermatitis Patients Using Topical Roflumilast Cream.
- Integrative Skin Science and Research, Sacramento
VärbamineFaas 4
Vanused 12 ja vanemad · Kõik sood · Uuendatud 13. aug 2026 · NCT07560618A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 1, Lancaster
- Inmagene Site 23, Los Angeles
VärbamineFaas 2
Vanused 18–74 · Kõik sood · Uuendatud 12. aug 2026 · NCT07037901A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Enveda Investigative Site, Encinitas
- Enveda Investigative Site, Los Angeles
- Enveda Investigative Site, Northridge
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 6. aug 2026 · NCT07643766A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
- Stanford University School of Medicine /ID# 269622, Palo Alto
- Integrative Skin Science and Research /ID# 265108, Sacramento
VärbamineFaas 3
Vanused 2–11 · Kõik sood · Uuendatud 6. aug 2026 · NCT06461897FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
- Anaheim Clinical Trials, LLC, Anaheim
- TCR Medical Corporation, San Diego
VärbamineFaas 1Terved vabatahtlikud oodatud
Vanused 18–70 · Kõik sood · Uuendatud 22. juuli 2026 · NCT06564389Sodium in the Skin and Atopic Dermatitis
- San Francisco VA Medical Center, San Francisco
- UCSF Mt Zion Campus, San Francisco
VärbamineVaatlusuuringTerved vabatahtlikud oodatud
Vanused 50 ja vanemad · Kõik sood · Uuendatud 14. juuli 2026 · NCT06998446A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
- Leo Pharma Investigational site, Palo Alto
- Leo Pharma Investigational site, Sacramento
- Leo Pharma Investigational site, San Diego
VärbamineFaas 3
6 Months – 11 Years · Kõik sood · Uuendatud 7. juuli 2026 · NCT06311682A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
- Exalt Clinical Research /ID# 281611, Chula Vista
- Private Practice - Dr. Tooraj Raoof /ID# 263849, Encino
- First OC Dermatology /ID# 263349, Fountain Valley
- ja veel 8
VärbamineFaas 3
Vanused 18–63 · Kõik sood · Uuendatud 6. juuli 2026 · NCT06389136Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
- University of California, San Diego: Dermatology Clinical Trials Unit, San Diego
VärbamineFaas 1
Vanused 6 ja vanemad · Kõik sood · Uuendatud 2. juuli 2026 · NCT06504160Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis
- First OC Dermatology, Fountain Valley
- Center for Dermatology Clinical Research, Inc., Fremont
- California Allergy and Asthma Medical Group, Los Angeles
- ja veel 1
VärbamineFaas 2
Vanused 18–65 · Kõik sood · Uuendatud 15. juuni 2026 · NCT06397911Molecular Signatures of Cutaneous Dupilumab Response
- University of California, San Francisco, San Francisco
VärbamineFaas 4
Vanused 18 ja vanemad · Kõik sood · Uuendatud 4. juuni 2026 · NCT05858619A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
- Marvel Clinical Research, Huntington Beach
- California Allergy and Asthma Medical Group, Los Angeles
- University Dermatology Trials, INC., Newport Beach
- ja veel 4
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 4. mai 2026 · NCT05995964Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
- Galderma Investigational Site - 7074, Corona
- Galderma Investigational Site 8636, Fountain Valley
- Galderma Investigational Site 8224, Fremont
- ja veel 4
VärbamineVaatlusuuring
Vanused 12 ja vanemad · Kõik sood · Uuendatud 13. märts 2026 · NCT06988605Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD
- Corvus Clinical Trials, South San Francisco
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 5. märts 2026 · NCT07441395Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECT
- University of California San Diego (UCSD), La Jolla
VärbamineVaatlusuuring
Kõik vanused · Naised · Uuendatud 28. jaan 2025 · NCT05938478A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab
- Physioseq, LLC /ID# 267266, Sacramento
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 24. jaan 2025 · NCT06524635Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.